MRI Driven Growth Target hospitals and ambulatory surgery centers investing in interventional MRI for electrophysiology to expand capabilities in cardiac ablation; position Imricor’s iCMR solutions as a differentiator for safer, imaging-enhanced procedures.

Finite Market Focus Leverage Imricor's specialized niche in iCMR for EP to pursue accounts within leading cardiology and rhythm management centers, while articulating clear value over traditional fluoroscopy-only ablation approaches.

Strategic Partnerships Explore collaborations with major electrophysiology device companies and MRI vendors to co-market or bundle imaging-enabled ablation workflows, expanding reach beyond standalone systems.

Proof of Value Highlight clinical and safety outcomes of MRI-guided ablation to build case studies and ROI analyses for procurement teams, emphasizing patient outcomes, procedure efficiency, and potential length-of-stay reductions.

Scale Fit Align sales outreach with mid-sized medical device and hospital networks (similar revenue range to peers) where Imricor’s size and agility can offer rapid deployment, service, and customization compared to larger incumbents.